Top Markets
Coin of the day
Imunon, Inc. Imunon, Inc.

Imunon, Inc.

CLSN
Rankning i aktier #35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Aktiekurs
$1.96
Senast synkroniserad: 2022-09-20
Marknadsvärde
$4.46M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Imunon, Inc. (CLSN)

Kategori

Historik för aktiesplit för Imunon, Inc. (CLSN)
Aktien Imunon, Inc. (symbol: CLSN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 16, 2026.
En CLSN-aktie köpt före Aug 16, 2026 motsvarar nu 0 CLSN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE